Citation Export
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Seung Hwan | - |
dc.contributor.author | Do, Ji Min | - |
dc.contributor.author | Yoo, Ji Na | - |
dc.contributor.author | Lee, Hyun Woo | - |
dc.contributor.author | Kim, Nam Kwon | - |
dc.contributor.author | Yoo, Hyung Seok | - |
dc.contributor.author | Gee, Min Sung | - |
dc.contributor.author | Kim, Jong Ho | - |
dc.contributor.author | Seong, Ji Hye | - |
dc.contributor.author | Inn, Kyung Soo | - |
dc.contributor.author | Seo, Min Duk | - |
dc.contributor.author | Lee, Jong Kil | - |
dc.contributor.author | Kim, Nam Jung | - |
dc.date.issued | 2021-08-01 | - |
dc.identifier.uri | https://dspace.ajou.ac.kr/dev/handle/2018.oak/32103 | - |
dc.description.abstract | In this study, polyhydroxyisoflavones that directly prevent the aggregation of both amyloid β (Aβ) and tau were expediently synthesized via divergent Pd(0)-catalyzed Suzuki-Miyaura coupling and then biologically evaluated. By preliminary structure–activity relationship studies using thioflavin T (ThT) assays, an ortho-catechol containing isoflavone scaffold was proven to be crucial for preventing both Aβ aggregation and tau-mediated neurofibrillary tangle formation. Additional TEM experiment confirmed that ortho-catechol containing isoflavone 4d significantly prevented the aggregation of both Aβ and tau. To investigate the mode of action (MOA) of 4d, which possesses an ortho-catechol moiety, 1H-15N HSQC NMR analysis was thoroughly performed and the result indicated that 4d could directly inhibit both the formation of Aβ42 fibrils and the formation of tau-derived neurofibrils, probably through the catechol-mediated nucleation of tau. Finally, 4d was demonstrated to alleviate cognitive impairment and pathologies related to Alzheimer's disease in a 5XFAD transgenic mouse model. | - |
dc.description.sponsorship | This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2020R1F1A1064755 and 2020R1A2C300888911). | - |
dc.language.iso | eng | - |
dc.publisher | Academic Press Inc. | - |
dc.subject.mesh | Alzheimer Disease | - |
dc.subject.mesh | Amyloid beta-Peptides | - |
dc.subject.mesh | Animals | - |
dc.subject.mesh | Brain | - |
dc.subject.mesh | Catechols | - |
dc.subject.mesh | Disease Models, Animal | - |
dc.subject.mesh | Drug Design | - |
dc.subject.mesh | Isoflavones | - |
dc.subject.mesh | Maze Learning | - |
dc.subject.mesh | Mice | - |
dc.subject.mesh | Mice, Inbred C57BL | - |
dc.subject.mesh | Mice, Transgenic | - |
dc.subject.mesh | Neurofibrillary Tangles | - |
dc.subject.mesh | Neuroprotective Agents | - |
dc.subject.mesh | Peptide Fragments | - |
dc.subject.mesh | Protein Aggregates | - |
dc.subject.mesh | tau Proteins | - |
dc.title | Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation | - |
dc.type | Article | - |
dc.citation.title | Bioorganic Chemistry | - |
dc.citation.volume | 113 | - |
dc.identifier.bibliographicCitation | Bioorganic Chemistry, Vol.113 | - |
dc.identifier.doi | 10.1016/j.bioorg.2021.105022 | - |
dc.identifier.pmid | 34098397 | - |
dc.identifier.scopusid | 2-s2.0-85108709897 | - |
dc.identifier.url | http://www.elsevier.com/inca/publications/store/6/2/2/7/9/4/index.htt | - |
dc.subject.keyword | Alzheimer's disease | - |
dc.subject.keyword | Amyloid β | - |
dc.subject.keyword | Catechol | - |
dc.subject.keyword | Polyhydroxyisoflavone | - |
dc.subject.keyword | Tau | - |
dc.description.isoa | false | - |
dc.subject.subarea | Biochemistry | - |
dc.subject.subarea | Molecular Biology | - |
dc.subject.subarea | Drug Discovery | - |
dc.subject.subarea | Organic Chemistry | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.